"10.1371_journal.pone.0150018","plos one","2016-03-01T00:00:00Z","Elizabeth A McKie; Juliet L Reid; Prafull C Mistry; Stephen L DeWall; Lee Abberley; Philip D Ambery; Blas Gil-Extremera","Respiratory R&D, GlaxoSmithKline, Uxbridge, United Kingdom; Immunoinflammation Therapy Area Unit, GlaxoSmithKline, Stevenage, United Kingdom; Clinical Statistics, GlaxoSmithKline, Stevenage, United Kingdom; Clinical Immunology, Biopharm R&D, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America; Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America; GlaxoSmithKline, Clinical development, Cardiovascular and Metabolic Medicines Development Centre, London, United Kingdom; Department of Medicine, University Hospital San Cecilio, Granada, Spain","Conceived and designed the experiments: Elizabeth A. McKie, Juliet L. Reid, Prafull C. Mistry, Stephen L. DeWall, Lee Abberley, Philip D. Ambery. Performed the experiments: Elizabeth A. McKie, Juliet L. Reid, Prafull C. Mistry, Stephen L. DeWall, Lee Abberley, Philip D. Ambery and Blas Gil-Extremera. Analyzed the data: Elizabeth A. McKie, Juliet L. Reid, Prafull C. Mistry, Stephen L. DeWall, Lee Abberley, Philip D. Ambery. Contributed reagents/materials/analysis tools: Elizabeth A. McKie, Juliet L. Reid, Prafull C. Mistry, Stephen L. DeWall, Lee Abberley, Philip D. Ambery and Blas Gil-Extremera. Wrote the paper: Elizabeth A. McKie, Juliet L. Reid, Prafull C. Mistry, Stephen L. DeWall, Lee Abberley, Philip D. Ambery and Blas Gil-Extremera. N/A.","Elizabeth A. McKie is an employee of GlaxoSmithKline. Juliet L. Reid is an employee and stockholder of GlaxoSmithKline. Prafull C. Mistry is an employee of GlaxoSmithKline. Stephen L. DeWall is an employee and stockholder of GlaxoSmithKline. Lee Abberley is an employee of GlaxoSmithKline. Philip D. Ambery was an employee of GlaxoSmithKline at time of study conduct and is currently an employee of MedImmune and a stockholder of AstraZeneca. Blas Gil-Extremera has nothing to disclose. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","03","Elizabeth A McKie","EAMK",7,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
